SEC Form 4 · accession 0001246360-17-003324
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G Funari
Director
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2017 | M | 18,196 | $13.60 | A | 28,346 | D | |
| Common Stock | Dec 12, 2017 | M | 7,173 | $11.27 | A | 35,519 | D | |
| Common Stock | Dec 12, 2017 | F | 12,682 | $25.89 | D | 22,837 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $13.60 | Dec 12, 2017 | M | 18,196 | D | May 23, 2013 | May 22, 2018 | Common Stock | 18,196 | 0 | D |
| Stock Option (Right to Buy) | $11.27 | Dec 12, 2017 | M | 7,173 | D | Jan 22, 2013 | Jan 21, 2018 | Common Stock | 7,173 | 0 | D |